Similarly, a number of deletion and missense mutations affecting the function of the RECQ5 SRI domain have been identified in breast cancer cases [78,79], suggesting the significance of the anti-tumor properties associated with the RECQ5 SRI domain across multiple cancer types. Here, RECQL5 is linked to breast cancer.